News

latest corporate presentation

Latest Summary Corporate Presentation

June 2024

View Presentation
03 Aug 2022 Actinogen Webcast video recording: Actinogen Clinical Trials Science Forum
03 Aug 2022 Actinogen Company presentation: Actinogen Clinical Trials Science Forum
28 Jul 2022 Actinogen Company presentation: CEO presentation to Spark Plus Australian Equities Day
14 Jun 2022 Actinogen Company presentation: CEO presentation for meetings at BIO International Convention
14 Jun 2022 Global Newswire Actinogen Announces Phase 2 Trials in Alzheimer’s Disease and Depression
11 May 2022 Actinogen Company presentation: Bioshares Biotech Summit 2022
04 May 2022 Actinogen Company presentation: ACW trial results & strategic update presentation
27 Apr 2022 Actinogen Webcast video recording: XanaMIA Part A Trial positive topline results for Xanamem
27 Apr 2022 Actinogen Company presentation: XanaMIA Part A Trial positive topline results for Xanamem
27 Apr 2022 news.com.au Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s
27 Apr 2022 The Australian Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s
27 Apr 2022 Actinogen Media Release: Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s by Aussie biotech Actinogen
01 Mar 2022 Actinogen Company presentation: CEO presents at Sachs 15th Annual European Life Sciences Conference
11 Feb 2022 The Market Herald Actinogen Medical (ASX:ACW) advances Alzheimer’s treatment
10 Jan 2022 Actinogen Company presentation: CEO presents at San Francisco Healthcare Conference
25 Nov 2021 Actinogen Webcast video recording: Strategic Update and Capital Raising Investor Presentation
25 Nov 2021 Actinogen Company presentation: Strategic Update & Capital Raising Investor Presentation
10 Nov 2021 Actinogen Webcast video recording: AGM 10 Nov 2021 ACW Chair’s Address and CEO presentation
10 Nov 2021 Actinogen Company presentation: AGM 10 Nov 2021 ACW Chair’s Address and CEO presentation
01 Oct 2021 Actinogen Company presentation: CEO presentation at conference call on 19 Oct 2021
15 Jul 2021 The Market Herald Actinogen Medical (ASX:ACW) enrols first patient in Alzheimer’s Disease trial
18 Jun 2021 Biotech Daily Dr Boreham’s Crucible: Actinogen Medical
10 Jun 2021 Actinogen Company presentation: BIO Digital 2021 (10-11 & 14-18 June 2021)
02 Jun 2021 The Market Herald Actinogen Medical (ASX:ACW) granted ethics committee approval for Alzheimers study
02 Jun 2021 Biotech Daily Actinogen: Part-A Xanamia Xanamem Cognition Trial Approved
30 Apr 2021 Actinogen Teleconference call transcript: Strategic Update and Investor Presentation
22 Apr 2021 Biotech Daily Actinogen Plans Three Phase II Cognition Trials For 2022
21 Apr 2021 Actinogen Company presentation: Strategic Update and Investor Presentation
15 Mar 2021 Biotech Daily Actinogen Appoints Dr Steven Gourlay CEO On $400k
11 Feb 2021 Biotech Daily Actinogen Shortfall Raises $3.55m – Total $10.9m
27 Nov 2020 Open Briefing Webcast video recording: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
27 Nov 2020 Actinogen Audio recording: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
27 Nov 2020 Actinogen Company presentation: AGM 27 Nov 2020 ACW Chair’s Address and Managing Director’s presentation
02 Nov 2020 Actinogen Company presentation: New clinical development opportunity Fragile X syndrome
28 Oct 2020 Actinogen Company presentation: Monsoon Morning Twilight Investor Briefing
19 Oct 2020 Actinogen Webcast video recording: Conference Call 19 Oct 2020
08 Sep 2020 ASX Webcast video recording: CEO presentation at ASX Small & Mid-Cap Conference (8-10 Sep 2020)
08 Sep 2020 Actinogen Company investor presentation: ASX Small & Mid-Cap Conference (8-10 Sep 2020)
31 Jul 2020 Actinogen Poster presentation: Alzheimer’s Association International Conference (AAIC) Virtual Event (27-31 Jul 2020) Poster presentation by Prof Craig Ritchie, Chair of Actinogen Xanamem Clinical Advisory Board on behalf of Actinogen “Drug Development Summary for Xanamem™, a Potent Inhibitor of the 11β-HSD1 Enzyme”
31 Jul 2020 Finance News Network Webcast video recording: CEO presentation to FNN CEO Showcase – FNN Online Investor Event, July 2020
15 Jul 2020 Actinogen Webcast video recording: CEO presentation at Bio Digital 2020
08 Jun 2020 Actinogen Company presentation: CEO presentation at Bio Digital 2020
08 Jun 2020 Actinogen Company presentation: CEO presentation for partnering meetings at BIO Digital 2020
29 Apr 2020 Actinogen Webcast video recording: Prof Craig Ritchie, Chair of ACW’s Xanamem Clinical Advisory Board presentation at AAT/AD-PD 2020
29 Apr 2020 Actinogen Company presentation summary: AAT-AD/PD 2020
29 Apr 2020 Actinogen Company presentation: Prof Craig Ritchie, Chair of ACW’s Xanamem Clinical Advisory Board presentation at AAT/AD-PD 2020
29 Jan 2020 Sachs TV Webcast video recording: CEO presentation at SACHS Neuroscience Innovation Forum in San Francisco, USA
08 Jan 2020 Actinogen Company presentation: CEO presentation at SACHS Neuroscience Innovation Forum and partnering meetings during JPM week
25 Nov 2019 Actinogen Webcast video recording: AGM 2019 ACW Managing Directors Address to Shareholders
25 Nov 2019 Actinogen Company presentation: AGM 2019 Managing Director’s Address to Shareholders

Back
to top